Lisa Carey
University of North Carolina

Last Updated On 7/11/2020 2:06:10 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
No Relationships to Disclose

Leadership
No Relationships to Disclose

Stock and Other Ownership Interests
No Relationships to Disclose

Honoraria
No Relationships to Disclose

Consulting or Advisory Role
No Relationships to Disclose

Speakers' Bureau
No Relationships to Disclose

Research Funding
Company: Innocrin Pharma
Recipient: Your Institution
Company: Syndax
Recipient: Your Institution
Company: Immunomedics
Recipient: Your Institution
Company: Novartis
Recipient: Your Institution
Company: NanoString Technologies
Recipient: Your Institution
Company: Abbvie
Recipient: Your Institution
Company: Seattle Genetics
Recipient: Your Institution

Patents, Royalties, Other Intellectual Property
Please describe: Royalty-sharing agreement, investorship interest in licensed IP to startup company, Falcon Therapeutics, that is designing neural stem cell-based therapy for glioblastoma multiforme.
Recipient: An Immediate Family Member

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
No Relationships to Disclose

Other Relationship
No Relationships to Disclose

(OPTIONAL) Uncompensated Relationships
Company: Sanofi-Aventis
Recipient: Your Institution
Company: Novartis
Recipient: Your Institution
Company: G1 Therapeutics
Recipient: Your Institution
Company: Genentech / Roche
Recipient: Your Institution
Company: GSK
Recipient: Your Institution

(OPTIONAL) Open Payments Link
Open Payments URL: https://openpaymentsdata.cms.gov/physician/179671